20/2023 Information on the conclusion by Medicalgorithmics S.A. with its registered office in Warsaw of a public procurement agreement for the supply of devices for continuous telemetry20/2023
Current report no.: 20/2023 Date of preparation: 17 August 2023 Legal basis: Article 17(1) of the MAR Regulation – inside information. The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company“) informs that on August 17, 2023 the Company concluded an agreement with the Prof. Leszek Giec Upper Silesian Medical Center of […]
19/2023 Information on the intention of Medicalgorithmics S.A. with its registered office in Warsaw to conclude a public procurement contract in connection with the selection of the Company’s offer as the most advantageous in the public procurement procedure19/2023
Current report no.: 19/2023 Date of preparation: 7 August 2023 Legal basis: Article 17(1) of the MAR Regulation – inside information. The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company“) informs about the intention to conclude an agreement for the supply of devices for continuous telemetry as part of the project […]
18/2023 Resolutions of the Ordinary General Meeting of Medicalgorithmics S.A. held on June 30, 202318/2023
Current Report No.: 18/2023 Date: 30.06.2023 Legal basis: Art. 56 sec. 1 point 2 of the Act on Public Offering – current and periodic information The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company“) publishes, in the form of attachments to this report, the content of resolutions adopted by the Ordinary […]
17/2023 List of shareholders holding at least 5 % of the total number of votes at the Ordinary General Meeting of Medicalgorithmics S.A. on 30 June 2023.
Current Report No.: 17/2023 Date: 30.06.2023 Legal basis: Article 70(3) of the Act on Public Offering — General Meeting list above 5 % The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company“), hereby informs that the shareholders present at the Ordinary General Meeting of the Company convened for June 30, 2023 […]
16/2023 Development strategy 2023 – 2026
Current Report No. 16/2023 Date: 19.06.2023 Legal basis: Article 17(1) of MAR – inside information The Management Board of Medicalgorithmics S.A. (the “Company“) informs that on June 19, 2023 it adopted the Development strategy of the Company and the Medicalgorithmics Capital Group for the years 2023 – 2026, which was approved by the Supervisory Board […]
15/2023 Assimilation of the Company’s series I shares with shares traded on the main market
Current Report No. 15/2023 Date of preparation: 2023-06-18 Legal basis: Art. 56 (1) (2) of the Public Offering Act – current and periodic information. The Management Board of MEDICALGORITHMICS S.A. with its seat in Warsaw [Issuer, Company], in reference to the Company’s current report No. 14/2023 of June 14, 2023, hereby informs that today it […]
14/2023 Medicalgorithmics and California Based DMS-Service Join Forcesfor Software Integration and Development
Medicalgorithmics S.A., a global leader in healthcare technology, and dms-service llc, a prominent provider of Holter Monitoring devices, are delighted to announce their collaboration on a software integration. This joint initiative aims to integrate the dms-service llc monitoring hardware with the cutting-edge Medicalgorithmics software platform, unlocking the potential for AI-powered algorithms and predictive analytics. The […]
13/2023 Information on convening the Ordinary General Meeting of Medicalgorithmics S.A. together with the content of draft resolutions
Current report no.: 13/2023 Date: 02.06.2023 Legal basis: Article 56 (1) (2) of the Offering Act – current and periodic information Management Board of Medicalgorithmics S.A. with its seat in Warsaw (“the Company“), hereby informs about the convening of the Ordinary General Meeting of the Company on June 30, 2023, at 2:00 pm at the […]
12/2023 Recommendation of the Management Board regarding the coverage of the loss for the financial year 2022
Current Report No. 12/2023 Date: 02.06.2023 Legal basis: Article 17(1) of MAR – inside information The Management Board of Medicalgorithmics S.A. (“Company“) informs that it adopted a resolution recommending to the Ordinary General Meeting of the Company to cover the net loss for 2022 in the amount of PLN 29 513 000 as follows: the […]
11/2023 Estimated financial results and provisional recognition of contribution in kind value according to IFRS in financial statements
Current report No.: 11/2023 Preparation date: April 21, 2023 Legal basis: Article 17(1) of the MAR Regulation – confidential information. The Management of Medicalgorithmics S.A., based in Warsaw, presents the draft selected financial results for 2022, both on a stand-alone and consolidated basis, with comparable data for 2021, as well as provisional recognition of the […]
10/2023 Medicalgorithmics subsidiary Kardiolytics’ VCAST technology receives new U.S. patent for autonomous segmentation using artificial intelligence for vascular disease diagnosis
Current report no.: 10/2023 Date of preparation: April 3, 2023. Legal basis: Article 17 par. 1 of the MAR Regulation – confidential information. The Management Board of Medicalgorithmics S.A. headquartered in Warsaw (“Company”) announces that its wholly-owned subsidiary, Kardiolytics Inc. (“Kardiolytics”), has been granted USA Patent No. 11626211. The Company has received notification from the […]
9/2023 Notifications of transactions of persons discharging managerial responsibilities received in accordance with Article 19 of the MAR Regulation
Current Report No. 9/2023 Date: 27.03.2023 r. Legal basis: Article 19(3) of the MAR Regulation – information on transactions performed by persons discharging managerial responsibilities The Management Board of Medicalgorithmics S.A. (the “Company“) informs, pursuant to Article 19(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 […]